Pandemic Effect: Sponsors Paid Far Fewer User Fees Than Expected In FY 2020

 
• By Derrick Gingery

Revenue increases are expected in FY 2021 over pre-pandemic estimates, in part because the US FDA believes sponsors may have applications that were delayed by COVID-19.

Revenue down
Fewer submissions in FY 2020 meant less user fee revenue for the FDA. • Source: Alamy

More from User Fees

More from Pathways & Standards